Following Monday’s clinical defeat by Eli Lilly, Novo Nordisk cut the 2027 list prices for its three GLP-1 medicines by as much as 50%, while boasting Phase 2 data for its invesigational triple-G agonist.

Novo Nordisk and Vivtex Corporation have entered into a partnership to develop next-generation oral biologic medicines for obesity, diabetes and associated comorbidities.

Ozempic maker's lawsuit, FDA enforcement could curtail sales of less expensive, compounded, versions of popular weight loss drugs.

Novo Nordisk is suing a Shrewsbury doctor who sells a cheaper compounded medicine version of its popular Ozempic and Wegovy weight-loss drugs.

Novo Nordisk announced plans to drastically reduce the list price of its versions, Wegovy, Ozempic and Rybelsus.

SUMMIT COUNTY — Racing, whether professional or recreational, is all about challenge and achievement. The USA Pro Challenge is an example of an international audience watching professional athletes test their limits against themselves, their competitors ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides absolute Count of primary research articles and fractional ...